Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2005 Apr 12;64(7):1267-9.

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Author information

Department of Neurology Mayo Clinic, Scottsdale, AZ 85259, USA.


Pharmacotherapeutic options for multiple sclerosis (MS)-related fatigue are limited. Thirty patients were randomly assigned to aspirin (ASA) 1,300 mg/day or placebo in a double-blind crossover study. Results favored ASA for the main clinical outcomes: Modified Fatigue Impact Scale scores (p = 0.043) and treatment preference (p = 0.012). There were no significant adverse effects. The results warrant further study and support a role for ASA-influenced mechanisms, perhaps immunologic, in the generation of MS-related chronic fatigue.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center